ArriVent BioPharma, Inc. - AVBP

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.021B

QoQ value delta ($000)

+$203.8M (+24.94%)

Implied price effect (QoQ)

+13.4%

Total shares

44,560,632

QoQ shares delta

+4,114,361 (+10.17%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 140 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
SUVRETTA CAPITAL MANAGEMENT, LLC	101,532	4,401,083	2.59%
INFINITUM ASSET MANAGEMENT, LLC	95,715	4,148,923	11.95%
HHLR ADVISORS, LTD.	90,644	3,929,117	5.42%
ORBIMED ADVISORS LLC	69,840	3,027,328	1.38%
FMR LLC	69,582	3,016,132	0.0%
BlackRock, Inc.	58,374	2,530,301	0.0%
Octagon Capital Advisors LP	45,472	1,971,054	5.03%
Novo Holdings A/S	44,805	1,942,142	3.63%
Sofinnova Investments, Inc.	39,144	1,696,752	1.49%
VANGUARD GROUP INC	37,609	1,869,266	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	35,271	1,528,893	0.0%
General Catalyst Group Management, LLC	34,484	1,494,786	18.79%
STATE STREET CORP	32,792	1,421,415	0.0%
Vivo Capital, LLC	20,438	885,916	1.7%
GOLDMAN SACHS GROUP INC	19,688	853,427	0.0%
GEODE CAPITAL MANAGEMENT, LLC	18,544	803,652	0.0%
Point72 Asset Management, L.P.	17,260	748,195	0.02%
HSG Holding Ltd	13,982	663,308	0.86%
Fund 1 Investments, LLC	11,534	499,990	1.32%
UBS Group AG	11,218	486,263	0.0%
BALYASNY ASSET MANAGEMENT L.P.	9,834	426,281	0.01%
MILLENNIUM MANAGEMENT LLC	9,826	425,923	0.0%
D. E. Shaw & Co., Inc.	8,508	368,795	0.01%
CITADEL ADVISORS LLC	8,149	353,257	0.0%
Logos Global Management LP	8,074	350,000	0.4%